Skip to main content
Top
Published in: Tumor Biology 6/2014

01-06-2014 | Research Article

Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism

Authors: Ling Zhou, Yuangang Lu, Guihong Yang, Jinjin Wu

Published in: Tumor Biology | Issue 6/2014

Login to get access

Abstract

Melanoma is a highly malignant tumor originating from melanocytes. This disease is characterized by inconspicuous onset, high malignancy, and poor prognosis. The aim of this study is to explore the effect of cinnamaldehyde on melanoma tumorigenicity and its mechanism. Melanoma cells were subcutaneously injected into a nude mouse to establish the tumour model. A comparison was made for the difference in formation and growth of melanoma cell tumor between normal saline and cinnamaldehyde. A comparison was also made for the number of new vessels between the normal saline group (the control group) and the cinnamaldehyde group (the experimental group) through immumohistochemical staining. The western blot was used to detect the difference in expression levels of vascularization related proteins. The results indicated that the volume of tumors formed and the number of new vessels in melanoma cells of the cinnamaldehyde group decreased significantly compared with those in the cells of the normal saline group. A further study indicated that the expression of hypoxia-inducible factor-a (HIF-α) and vascular endothelial growth factor (VEGF) in the melanoma of the cinnamaldehyde group decreased significantly. In conclusion, cinnamaldehyde plays a certain role in inhibiting the occurrence and progression of melanoma and its action mechanism may be manifested by inhibiting expression of VEGF and HIF-α, thus blood vessel simulation and formation of new blood vessels of melanoma cells, and growth of tumors accordingly.
Literature
1.
go back to reference Wu BJ, Li WP, Qian C, Ding W, Zhou ZW, Jiang H. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma. Tumor Biol. 2013;34(2):643–8.CrossRef Wu BJ, Li WP, Qian C, Ding W, Zhou ZW, Jiang H. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma. Tumor Biol. 2013;34(2):643–8.CrossRef
2.
go back to reference Stevenson AD, Mickan S, Mallett S, Ayya M. Systematic review of diagnostic accuracy of reflectance confocal microscopy for melanoma diagnosis in patients with clinically equivocal skin lesions. Dermatol Pract Concept. 2013;3(4):19–27.PubMedCentralCrossRefPubMed Stevenson AD, Mickan S, Mallett S, Ayya M. Systematic review of diagnostic accuracy of reflectance confocal microscopy for melanoma diagnosis in patients with clinically equivocal skin lesions. Dermatol Pract Concept. 2013;3(4):19–27.PubMedCentralCrossRefPubMed
3.
go back to reference Kawczyk-Krupka A, Bugaj AM, Latos W, Zarebma K, Sieron A. Photodynamic therapy in treatment of cutaneous and choroidal melanoma. Photodiagnosis Photodyn Ther. 2013;10(4):503–9.CrossRefPubMed Kawczyk-Krupka A, Bugaj AM, Latos W, Zarebma K, Sieron A. Photodynamic therapy in treatment of cutaneous and choroidal melanoma. Photodiagnosis Photodyn Ther. 2013;10(4):503–9.CrossRefPubMed
5.
go back to reference Covarelli P, Burini G, Barberini F, Caracappa D, Boselli C, Noya G, et al. The integrated role of ultrasonography in the diagnosis of soft tissue metastases from melanoma: preliminary report of a single-center experience and literature review. In Vivo. 2013;27(6):827–33.PubMed Covarelli P, Burini G, Barberini F, Caracappa D, Boselli C, Noya G, et al. The integrated role of ultrasonography in the diagnosis of soft tissue metastases from melanoma: preliminary report of a single-center experience and literature review. In Vivo. 2013;27(6):827–33.PubMed
6.
go back to reference Freeman SR, Gibbs BB, Brodland DG, Zitelli JA. Prognostic value of sentinel lymph node biopsy compared with that of breslow thickness: implications for informed consent in patients with invasive melanoma. Dermatol Surg. 2013;39(12):1800–12.CrossRefPubMed Freeman SR, Gibbs BB, Brodland DG, Zitelli JA. Prognostic value of sentinel lymph node biopsy compared with that of breslow thickness: implications for informed consent in patients with invasive melanoma. Dermatol Surg. 2013;39(12):1800–12.CrossRefPubMed
7.
go back to reference Wondrak GT, Villeneuve NF, Lamore SD, Bause AS, Jiang T, Zhang DD. The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells. Molecules. 2010;15(5):3338–55.PubMedCentralCrossRefPubMed Wondrak GT, Villeneuve NF, Lamore SD, Bause AS, Jiang T, Zhang DD. The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells. Molecules. 2010;15(5):3338–55.PubMedCentralCrossRefPubMed
8.
go back to reference Song F, Li H, Sun J, Wang S. Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats. J Ethnopharmacol. 2013;150(1):125–30.CrossRefPubMed Song F, Li H, Sun J, Wang S. Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats. J Ethnopharmacol. 2013;150(1):125–30.CrossRefPubMed
9.
go back to reference Cabello CM, Bair WB, Lamore SD, Ley S, Bause AS, Azimian S, et al. The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med. 2009;46(2):220–31.PubMedCentralCrossRefPubMed Cabello CM, Bair WB, Lamore SD, Ley S, Bause AS, Azimian S, et al. The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med. 2009;46(2):220–31.PubMedCentralCrossRefPubMed
10.
go back to reference Sato A, Yoshikawa N, Kubo E, Kakuda M, Nishiuchi A, Kimoto Y, et al. Inhibitory effect of cordycepin on experimental hepatic metastasis of b16-f0 mouse melanoma cells. In Vivo. 2013;27(6):729–832.PubMed Sato A, Yoshikawa N, Kubo E, Kakuda M, Nishiuchi A, Kimoto Y, et al. Inhibitory effect of cordycepin on experimental hepatic metastasis of b16-f0 mouse melanoma cells. In Vivo. 2013;27(6):729–832.PubMed
11.
go back to reference O’Reilly KE, Miera EV, Segura MF, Friedman E, Poliseno L, Han SW, et al. Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo. Pharmaceuticals (Basel). 2013;6(11):1429–50.CrossRef O’Reilly KE, Miera EV, Segura MF, Friedman E, Poliseno L, Han SW, et al. Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo. Pharmaceuticals (Basel). 2013;6(11):1429–50.CrossRef
12.
go back to reference Gunaldi M, Paydas S, Afsar CU, Doran F. Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Med J. 2013;54(11):233–5.CrossRef Gunaldi M, Paydas S, Afsar CU, Doran F. Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Med J. 2013;54(11):233–5.CrossRef
13.
go back to reference Wolf SE, Meenken C, Moll AC, Haanen JB, van der Heijden MS. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma. BMC Cancer. 2013;13(1):561–5.PubMedCentralCrossRefPubMed Wolf SE, Meenken C, Moll AC, Haanen JB, van der Heijden MS. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma. BMC Cancer. 2013;13(1):561–5.PubMedCentralCrossRefPubMed
14.
go back to reference Robles FE, Wilson JW, Warren WS. Quantifying melanin spatial distribution using pump-probe microscopy and a 2-D morphological autocorrelation transformation for melanoma diagnosis. J Biomed Opt. 2013;18(12):502–6.CrossRef Robles FE, Wilson JW, Warren WS. Quantifying melanin spatial distribution using pump-probe microscopy and a 2-D morphological autocorrelation transformation for melanoma diagnosis. J Biomed Opt. 2013;18(12):502–6.CrossRef
15.
go back to reference Gaustad JV, Pozdniakova V, Hompland T, Simonsen TG, Rofstad EK. Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts. J Exp Clin Cancer Res. 2013;32(1):93–6.PubMedCentralCrossRefPubMed Gaustad JV, Pozdniakova V, Hompland T, Simonsen TG, Rofstad EK. Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts. J Exp Clin Cancer Res. 2013;32(1):93–6.PubMedCentralCrossRefPubMed
16.
go back to reference Caraco C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis. BMC Cancer. 2013;13(1):564–8.PubMedCentralCrossRefPubMed Caraco C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis. BMC Cancer. 2013;13(1):564–8.PubMedCentralCrossRefPubMed
17.
go back to reference Feletti A, Magrini S, Manara R, Orvieto E, Pavesi G. Intraventricular melanoma metastases. Neurol India. 2013;61(5):547–8.CrossRefPubMed Feletti A, Magrini S, Manara R, Orvieto E, Pavesi G. Intraventricular melanoma metastases. Neurol India. 2013;61(5):547–8.CrossRefPubMed
18.
go back to reference Curry JL, Davies MA, Calderone TL, Nathanson K, Prieto VG, Gershenwald JE. Tissue resources for clinical use and marker studies in melanoma. Methods Mol Biol. 2013;1102:679–95.CrossRef Curry JL, Davies MA, Calderone TL, Nathanson K, Prieto VG, Gershenwald JE. Tissue resources for clinical use and marker studies in melanoma. Methods Mol Biol. 2013;1102:679–95.CrossRef
19.
go back to reference Sjoestroem C, Khosravi S, Zhang G, Martinka M, Li G. C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients. PLoS One. 2013;8(11):492–6.CrossRef Sjoestroem C, Khosravi S, Zhang G, Martinka M, Li G. C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients. PLoS One. 2013;8(11):492–6.CrossRef
20.
go back to reference Mo H, Ouyang D, Xu L, Gao Q, He X. Human endogenous retroviral syncytin exerts inhibitory effect on invasive phenotype of B16F10 melanoma cells. Chin J Cancer Res. 2013;25(5):556–64.PubMedCentralPubMed Mo H, Ouyang D, Xu L, Gao Q, He X. Human endogenous retroviral syncytin exerts inhibitory effect on invasive phenotype of B16F10 melanoma cells. Chin J Cancer Res. 2013;25(5):556–64.PubMedCentralPubMed
21.
go back to reference Pinto A, Merino M, Zamora P, Redondo A, Castelo B, Espinosa E. Targeting the endothelin axis in prostate carcinoma. Tumor Biol. 2012;33(2):421–6.CrossRef Pinto A, Merino M, Zamora P, Redondo A, Castelo B, Espinosa E. Targeting the endothelin axis in prostate carcinoma. Tumor Biol. 2012;33(2):421–6.CrossRef
22.
go back to reference Wagner BP, Epperla N, Medina-Flores R. Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma – a case report. Diagn Pathol. 2013;8(1):192–6.PubMedCentralCrossRefPubMed Wagner BP, Epperla N, Medina-Flores R. Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma – a case report. Diagn Pathol. 2013;8(1):192–6.PubMedCentralCrossRefPubMed
23.
go back to reference Bergamo P, Cocca E, Palumbo R, Gogliettino M, Rossi M, Palmieri G. RedOx Status, Proteasome and APEH: Insights into Anticancer Mechanisms of t10, c12-Conjugated Linoleic Acid Isomer on A375 Melanoma Cells. PLoS One. 2013;8(11):900–6.CrossRef Bergamo P, Cocca E, Palumbo R, Gogliettino M, Rossi M, Palmieri G. RedOx Status, Proteasome and APEH: Insights into Anticancer Mechanisms of t10, c12-Conjugated Linoleic Acid Isomer on A375 Melanoma Cells. PLoS One. 2013;8(11):900–6.CrossRef
24.
go back to reference Shah AA, Bourne TD, Murali R. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology. 2013;45(7):651–6.CrossRefPubMed Shah AA, Bourne TD, Murali R. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology. 2013;45(7):651–6.CrossRefPubMed
26.
go back to reference Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, et al. Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts. J Exp Clin Cancer Res. 2013;32(1):91–4.PubMedCentralCrossRefPubMed Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, et al. Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts. J Exp Clin Cancer Res. 2013;32(1):91–4.PubMedCentralCrossRefPubMed
27.
go back to reference Micali G, Lacarrubba F, Bhatt K, Nasca MR. Medical approaches to non-melanoma skin cancer. Expert Rev Anticancer Ther. 2013;13(12):1409–21.CrossRefPubMed Micali G, Lacarrubba F, Bhatt K, Nasca MR. Medical approaches to non-melanoma skin cancer. Expert Rev Anticancer Ther. 2013;13(12):1409–21.CrossRefPubMed
28.
go back to reference Kakavand H, Scolyer RA, Thompson JF, Mann GJ. Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. Oncoimmunology. 2013;2(9):564–8.CrossRef Kakavand H, Scolyer RA, Thompson JF, Mann GJ. Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. Oncoimmunology. 2013;2(9):564–8.CrossRef
29.
go back to reference Lee SW, Kim SG, Park YW, Kweon HY, Kim JY, Rotaru H. Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study. Tumor Biol. 2013;34(3):1595–603.CrossRef Lee SW, Kim SG, Park YW, Kweon HY, Kim JY, Rotaru H. Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study. Tumor Biol. 2013;34(3):1595–603.CrossRef
Metadata
Title
Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism
Authors
Ling Zhou
Yuangang Lu
Guihong Yang
Jinjin Wu
Publication date
01-06-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1757-8

Other articles of this Issue 6/2014

Tumor Biology 6/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine